席夫堿雙氧釩(Ⅴ)配合物的合成、結(jié)構(gòu)及其抑制幽門螺旋桿菌脲酶研究

由忠錄獻(xiàn)冬梅 張 梅 孫 慧 李海華

(遼寧師范大學(xué)化學(xué)化工學(xué)院，大連 116029)

席夫堿雙氧釩(Ⅴ)配合物的合成、結(jié)構(gòu)及其抑制幽門螺旋桿菌脲酶研究

由忠錄＊獻(xiàn)冬梅 張 梅 孫 慧 李海華

(遼寧師范大學(xué)化學(xué)化工學(xué)院，大連 116029)

本文合成了2個雙氧釩(V)配合物，[VO2L1](1)和[VO2L2]2(2)(L1=4-氯-2-[(2-苯胺基乙亞胺基)甲基]苯酚鹽；L2=4-[2-(2-{[1-(5-氯-2-羥基苯基)甲亞胺基]胺基}乙胺基)乙亞胺基]-2-戊酮)，并通過物理化學(xué)方法和單晶X-射線衍射表征了它們的結(jié)構(gòu)。在單核配合物1中，V原子采取畸變的四方錐配位構(gòu)型，在雙核配合物2中，V原子采取八面體配位構(gòu)型。研究了這2個配合物對幽門螺旋桿菌脲酶的抑制活性。在濃度為100 μmol·L-1時，配合物1和2對脲酶的抑制率分別為(52.1±1.8)%和(34.2±3.3)%。還做了配合物和幽門螺旋桿菌脲酶的分子對接研究。配合物的結(jié)構(gòu)和其抑制脲酶活性的關(guān)系表明，配合物分子的尺寸和形狀對脲酶的抑制作用具有重要影響。

席夫堿；釩氧(Ⅴ)配合物；晶體結(jié)構(gòu)；抑制脲酶

Urease (urea amidohydrolase;E.C.3.5.1.5)is a nickel-containing metalloenzyme that catalyzes the hydrolysis of urea to form ammonia and carbamate[1-2].The resulting carbamate spontaneously decomposes to yield a second molecule of ammonia and carbon dioxide.High concentration of ammonia arising from these reactions,as well as the accompanying pH elevation,hasimportantnegative implicationsinmedicine and agriculture[3-6].Control of the activity of urease through the use of inhibitors could counteract these negative effects.In recent years,urease inhibitors play an important role in the treatment of the infections caused by urease producing bacteria[7].Inhibitors of urease can be broadly classified into two fields:(1)organic compounds,such as acetohydroxamic acid,humic acid,and 1,4-benzoquinone[8-10];(2)heavy metal ions,such as Cu2+,Zn2+,Pd2+,and Cd2+[11-12].The complexes containing metal atoms as urease inhibitors have seldom been reported,which indicatesthatthe organotin(Ⅴ),bismuth(Ⅴ),copper(Ⅴ),and cadmium(Ⅴ)complexes bearing interesting urease inhibitory activities[13-19].Vanadium complexes have been widely investigated in biological chemistry,especially for their insulin-enhancing activities.After searching the literature,we noticed that the vanadium complexes also possess interesting urease inhibitory activity[20].As an extensive study on the oxovanadium complexes and their urease inhibitory activity,in this paper,two new dioxovanadium (Ⅴ)complexes,[VO2L1](1)and[VO2L2]2(2),where L1is 4-chloro-2-[(2-phenylaminoethylimino)methyl]phenolate,and L2is4-[2-(2-{[1-(5-chloro-2-hydroxyphenyl)methylidene]amino}ethylamino)ethylimino]pentan-3-en-2-one),have been synthesized and structurally characterized.The urease inhibitory activity of the complexes and the molecular docking analysis of the complexes with Helicobacter pylori urease were investigated.

1 Experimental

1.1 General methods and materials

Starting materials,reagents and solvents were purchased from commercial suppliers and purified before use.Elemental analyses were performed on a Perkin-Elmer 240C elemental analyzer.The IR spectra were recorded on a Jasco FT/IR-4000 spectrometer as KBr pellets in the 4 000～200 cm-1region.The1HNMR spectra were recorded on a Bruker AVANCE 400 MHz spectrometer with tetramethylsilane as the internal reference.Molar conductance was measured with a Shanghai DDS-11A conductometer.X-ray diffraction was carried out on a Bruker SMART 1000 CCD diffractometer.

1.2 Synthesis of the complexes

[VO2L1](1):4-Chlorosalicylaldehyde (0.156 g,1 mmol)and N-phenylethane-1,2-diamine (0.136 g,1 mmol)were mixed in methanol(30 mL).The mixture was stirred at ambient temperature for 30 min to give yellow solution.To the solution was added with stirring a methanolic solution(15 mL)of VO(acac)2(0.27 g,1 mmol).The final mixture was further stirred for 30 min at ambient temperature to give a deep brown solution.Upon standing at room temperature,brown blockshaped crystalsof1,suitableforX-raycrystal structural determination were formed.The crystals were isolated,washed three times with cold methanol and dried in air.Yield 53%.IR data(cm-1):3221(sh,w),1628(s),1602(m),1541(m),1494(m),1466(s),1385(w),1 304(m),1 202(w),1 183(m),1 135(w),1 092(w),1 044(w),928(s),825(m),755(m),710(m),688(w),660(w),543(m),467(w),405(w).Anal.Calcd.for C15H14ClN2O3V(%):C,50.5;H,4.0;N,7.9.Found(%):C,50.2;H,4.1;N,7.8.

[VO2L2]2(2):4-Chlorosalicylaldehyde(0.156 g,1 mmol)dissolved in methanol(20 mL)was added slowly to the methanolic solution (30 mL)of diethylenetriamine(0.136 g,1 mmol)with continuous stirring for 30 min.To the yellow solution was added with stirring a methanolic solution (15 mL)of VO(acac)2(0.27 g,1 mmol).The final mixture was further stirred for 30 min at ambient temperature to give a deep brown solution.Upon standing at room temperature,brown blockshaped crystals of 2,suitable for X-ray crystal structural determination were formed.The crystals were isolated,washed three times with cold methanol and dried in air.Yield 63%.IR data(cm-1):3225(sh,w),1634(s),1575(m),1539(m),1465(m),1420(w),1383(m),1 303(m),1 280(m),1 185(w),1 092(w),1 009(w),930(s),843(m),711(m),661(w),646(w),558(w),471(w).Anal.Calcd.for C32H42Cl2N6O8V2(%):C,47.4;H,5.2;N,10.4.Found(%):C,47.7;H,5.3;N,10.2.

1.3 X-ray crystallography

Diffraction intensities for the complexes were collected at 298(2)K using a Bruker SMART 1000 CCD area-detector diffractometer with Mo Kα radiation(λ=0.071 073 nm).The collected data were reduced with the SAINT program[21],and multi-scan absorption correction was performed using the SADABS program[22].The structures were solved by direct method.The complexes were refined against F2by full-matrix leastsquares method using the SHELXTL package[23].All of the non-hydrogen atoms were refined anisotropically.The amino H atoms in the complexes were located from difference Fourier maps and refined isotropically,with N-H distances restrained to 0.090(1)nm.The remaining hydrogen atoms were placed in calculated positions and constrained to ride on their parent atoms.The crystallographicdataforthecomplexesare summarized in Table 1.Selected bond lengths and angles are given in Table 2.Crystallographic data for the complexes have been deposited with the Cambridge Crystallographic Data Centre.

CCDC:832899,1;832900,2.

Table 1 Crystal data for the complexes

Table 2 Selected bond lengths(nm)and angles(°)for the complexes

Continued Table 2

1.4 Urease inhibitory activity assay

Helicobacter pylori(ATCC 43504;American Type Culture Collection,Manassas,VA)was grown in brucella broth supplemented with 10%heat-inactivated horse serum for 24 h at 37℃under microaerobic condition(5%O2,10%CO2,and 85%N2).The method of preparation of Helicobacter pylori urease by Mao[24]was followed.Briefly,broth cultures(50 mL,2.0×108CFU·mL-1)were centrifuged (5 000 g,4℃)to collect the bacteria,and after washing twice with phosphatebuffered saline (pH 7.4),the Helicobacter pylori precipitation was stored at-80℃.While the Helicobacter pylori was returned to room temperature,and mixed with 3 mL of distilled water and protease inhibitors,sonication was performed for 60 s.Following centrifugation (15 000 g,4℃),the supernatant was desalted through SephadexG-25 column (PD-10 columns,Amersham-Pharmacia Biotech,Uppsala,Sweden).The resultant crude urease solution was added to an equal volume of glycerol and stored at 4℃until use in the experiment.The mixture,containing 25 μL(4U)of Helicobacter pylori urease and 25 μL of the test compound,waspre-incubated for3 h atroom temperature in a 96-well assay plate.Urease activity was determined by measuring ammonia production using the indophenolmethod as described by Weatherburn[25].

1.5 Molecular docking study

Molecular docking of the complexes into the 3D X-ray structures of Helicobacter pylori urease structure(entry 1E9Y in the Protein Data Bank)was carried out by using the AutoDock 4.2 software as implemented through the graphical user interface AutoDockTools(ADT 1.5.4).

The graphical user interface Auto Dock Tools was employed to setup the enzymes:all hydrogens were added,Gasteiger charges were calculated and non-polar hydrogens were merged to carbon atoms.The Ni initial parameters are set as r=0.117 nm,q=+2.0,and van der Waals well depth of 0.418 kJ·mol-1[26].The Auto Dock Tools was used to generate the docking input files.In the docking grid box size of 6.6 nm×5.0 nm×5.0 nm for 1 and 11.0 nm×8.0 nm×7.0 nm for 2 points in x,y,and z directions were built,the maps were centered on the original ligand molecule in the catalytic site of the protein.A grid spacing of 0.037 5 nm and a distancesdependent function of the dielectric constant were used for the calculation of the energetic map.100 runs were generated by using Lamarckian genetic algorithm searches.Default settings were used with an initial population of 50 randomly placed individuals,a maximum number of 2.5×106energy evaluations,and a maximum number of 2.7×104generations.A mutation rate of 0.02 and a crossover rate of 0.8 were chosen.The results of the most favorable free energy of binding were selected as the resultant complex structures.

2 Results and discussion

2.1 Chemistry

The Schiff bases 4-chloro-2-[(2-phenylaminoethylimino)methyl]phenol and 2-{[2-(2-aminoethylamino)ethylimino]methyl}-4-chlorophenol were prepared by the reaction of5-chlorosalicylaldehyde with N-phenylethane-1,2-diamine and diethylenetriamine,respectively,in methanol.The Schiff bases were not isolated and purified,which were further used to prepare the dioxovanadium complexes with VO(acac)2(Scheme 1).It is interesting that the amino group of 2-{[2-(2-aminoethylamino)ethylimino]methyl}-4-chlorophenol was condensed with the carbonyl group of VO(acac)2,generating a new ligand 4-[2-(2-{[1-(5-chloro-2-hydroxyphenyl)methylidene]amino}ethylamino)ethylimino]pentan-3-en-2-one.The single crystalswere obtained by slow evaporation of the methanolic solution of the complexes.Both complexes are stable in air at room temperature.The molar conductivity of the complexes measured in methanol at concentration of approximately 10-3mol·L-1are 18 Ω-1·cm2·mol-1for 1,and 30 Ω-1·cm2·mol-1for 2,indicating the nonelectrolytic nature of the complexes in solution[27].

Scheme 1 Preparation of the complexes

2.2 Structure description of the complexes

The molecular structure of the complex 1 is shown in Fig.1.X-ray crystallography reveals that the complex is a mononuclear dioxovanadium (Ⅴ)compound.The V atom is five-coordinated through two bonds to oxo groups and through three bonds to the Schiff base ligand L1.The Schiff base serves as a tridentate ligand to form a five-and a six-membered chelate rings with the V atom in the complex.The coordination geometry around the metal center in each of the complexes can be best described as a distorted square pyramid,with τ parameter of 0.40(τ=0 for an ideal square pyramid;τ=1 for an ideal trigonal bipyramid).The three donor atoms of the Schiff base ligand and one oxo O atom define the basal plane of the square pyramidal geometry,and the other oxo O atom occupies the apical position.The V atom lies 0.0479(2)nm from the leastsquares plane of the basal donor atoms,in the direction of the axial oxo ligand.The bond distances between the V atom and the oxo O atoms indicate that they aretypical double bonds.The coordinate bond distances and angles in the complex are comparable to those observed in other similar oxovanadium (Ⅴ)complexes with Schiff bases[28-29].In the crystal structure of1,molecules are linked through intermolecular N-H…O hydrogen bonds,to form chains running along the b axis,as shown in Fig.2.

Fig.1 A perspective view of the molecular structure of 1 with the thermal ellipsoids drawn at 30%probability level

Fig.2 Molecular packing of 1 viewed along the c axis

The molecular structure of the complex 2 is shown in Fig.3.X-ray crystallography reveals that the complex is a dinuclear dioxovanadium (Ⅴ)compound,with the V…V distance of 0.3122(1)nm.There are two N-H…O hydrogen bonds between the two Schiff base ligands.Each V atom in the complex is six-coordinated through three bonds to oxo groups and through three bonds to the Schiff base ligand L2,forming an octahedral geometry.The distances between atoms V1 and O6,V1 and O7,V2 and O5,and V2 and O8 are in the range 0.160 3(4)～0.166 9(3)nm,indicating they are typical V=O bonds.The oxo O5 and O6 atoms act as bridging groups.The coordinate bond lengths in the complex are comparable to those observed in other similar oxovanadium(V)complexes with Schiff bases[30-31].The distortion ofthe octahedralcoordination can be observed by the coordinate bond angles,ranging from 76.7(2)°to 106.5(2)°for V1,and from 76.7(1)°to 107.0(2)°for V2,for the perpendicular angles,and from 155.8(2)°to 171.1(2)°for V1,and from 155.4(2)°to 169.2(2)°for V2,for the diagonal angles.

Fig.3 A perspective view of the molecular structure of 2 with the thermal ellipsoids are drawn at the 30%probability level

2.3 Pharmacology

The results of the urease inhibition are summarized in Table 3.The acetohydroxamic acid(AHA)was used as a reference.Complex 1 show effective unease inhibitory activity,while that of the complex 2 is very weak.The IC50value ((63.3±3.8)μmol·L-1)for 1 was determined since it has effective activity.The results indicate that the inhibitory activity of 1 is much better than the vanadyl sulfate with an IC50value of(207.13±3.10) μmol·L-1.However,when compared with the acetohydroxamic acid,the activity of 1 is relatively weak.

Table 3 Inhibition of urease by the tested materials

2.4 Molecular docking study

The molecular docking study was performed to investigate the binding effects between the complexes and the active sites of the Helicobacter pylori urease.In the X-ray structure available for the native Helicobacter pylori urease,the two nickel atoms were coordinated by His136,His138,Kcx219,His248,His274,Asp362 and water molecules,while in the AHA-inhibited urease,these water molecules were replaced by AHA[32].In order to give an explanation and understanding of the inhibitory activity of the complexes,molecular docking of the complexes 1 and 2 into the AHA binding site ofthe urease was performed on the binding model based on the Helicobacter pylori urease complex structure(1E9Y.pdb).The binding models of the complexes 1 and 2 with the urease were depicted in Figs.4 and 5.It can be seen that the complex molecule of 1 is well filled in the active pocket of the urease,while that of 2 is located at the surface of the active pocket.The binding energy of the complexes with the urease are-1.325 kJ·mol-1for 1 and-0.222 kJ·mol-1for 2,which are higher than that of the AHA (-2.094 kJ·mol-1).The possible explanation is that the size of complex 2 is too large,and can not enter the pocket of the active center of urease,while that of 1 is relatively small,and forms several short contacts with the residues of the active sites.The results of the molecular docking study agree well with the inhibitory test,and could explain the activity of the complexes against Helicobacter pylori urease.

Fig.4 Binding mode of 1 with Helicobacter pylori urease

Fig.5 Binding mode of 2 with Helicobacter pylori urease

3 Conclusions

The present study reports the synthesis and structures of two new dioxovanadium (Ⅴ)complexes with Schiff bases. The structure-activity relationship indicates that the size of the molecules of the complexes play an important role in the urease inhibition.Considering that the oxovanadium complexes have interesting biological activities and have been widely used in medicine,further work need to be carried out to investigate the inhibitory mechanism of the complex 1.

[1]Karplus P A,Pearson M A,Hausinger R P.Acc.Chem.Res.,1997,30:330-337

[2]Sumner J B.J.Biol.Chem.,1926,69:435-441

[3]Zonia L E,Stebbins N E,Polacco J C.Plant Physiol.,1995,107:1097-1103

[4]Collins C M,Dórazio S E F.Mol.Microbiol.,1993,9:907-913

[5]Montecucco C,Rappuoli R.Nat.Rev.Mol.Cell Biol.,2001,2:457-466

[6]Zhengping W,Van Cleemput O,Demeyer P,et al.Biol.Fertil.Soils,1991,11:43-47

[7]Krajewska B.J.Mol.Catal.B.Enzym.,2009,59:9-21

[8]Amtul Z,Atta-ur-Rahman,Siddiqui R A,et al.Curr.Med.Chem.,2002,9:1323-1348

[9]Zaborska W,Kot M,Superata K.J.Enzym.Inhib.Med.Chem.,2002,17:247-253

[10]Pearson M A,Michel L O,Hausinger R P,et al.Biochemistry,1997,36:8164-8172

[11]Zaborska W,Krajewska B,Olech Z.J.Enzym.Inhib.Med.Chem.,2004,19:65-69

[12]Zaborska W,Krajewska B,Leszko M,et al.J.Mol.Catal.B:Enzym.,2001,13:103-108

[13]Asato E,Kamamuta K,Akamine Y,et al.Bull.Chem.Soc.Jpn.,1997,70:639-648

[14]Khan M I,Baloch M K,Ashfaq M.J.Enzym.Inhib.Med.Chem.,2007,22:343-350

[15]Hou P,You Z L,Zhang L,et al.Transition Met.Chem.,2008,33:1013-1017

[16]You Z L,Han X,Zhang G N.Z.Anorg.Allg.Chem.,2008,634:142-146

[17]Tanaka T,Kawase M,Tani S.Life Sci.,2003,73:2985-2990

[18]Cheng K,You Z L,Zhu H L.Aust.J.Chem.,2007,60:375-379

[19]You Z L,Ni L L,Shi D H,et al.Eur.J.Med.Chem.,2010,45:3196-3199

[20]Ara R,Ashiq U,Mahroof-Tahir M,et al.Chem.Biodivers.,2007,4:58-71

[21]Bruker,SMART and SAINT.Bruker AXS Inc,Madison,2002.

[22]Sheldrick G M.SADABS,University of G?ttingen,Germany,1996.

[23]Sheldrick G M.SHELXTL V5.1,Software Reference Manual,Bruker AXS Inc,Madison,1997.

[24]Mao W J,Lv P C,Shi L,et al.Bioorg.Med.Chem.,2009,17:7531-7536

[25]Weatherburn M W.Anal.Chem.,1967,39:971-974

[26]Krajewska B,Zaborska W.Bioorg.Chem.,2007,35:355-365

[27]Geary W J.Coord.Chem.Rev.,1971,7:81-122

[28]Kwiatkowski E,Romanowski G,Nowicki W,et al.Polyhedron,2003,22:1009-1018

[29]Asgedom G,Sreedhara A,Kivikoski J,et al.Dalton Trans.,1996:93-97

[30]LI Lian-Zhi(李連之),XU Tao(許濤),WANG Da-Qi(王大奇),et al.Chinese J.Inorg.Chem.(Wuji Huaxue Xuebao),2004,20(2):236-240

[31]ZHANG Xiao-Mei(張小梅),ZHOU Yin-Zhuang(周蔭莊),TU Shu-Jie(屠淑潔),et al.Chinese J.Inorg.Chem.(Wuji Huaxue Xuebao),2007,23(10):1700-1704

[32]Xiao Z P,Ma T W,Fu W C,et al.Eur.J.Med.Chem.,2010,45:5064-5070

Synthesis and Structures of Dioxovanadium(Ⅴ)Complexes with Schiff Bases and Their Inhibition Studies on Helicobacter Pylori Urease

YOU Zhong-Lu＊XIAN Dong-MeiZHANG MeiSUN HuiLI Hai-Hua
(Department of Chemistry and Chemical Engineering,Liaoning Normal University,Dalian,Liaoning 116029,China)

Two dioxovanadium(Ⅴ)complexes,[VO2L1](1)and[VO2L2]2(2)(L1=4-chloro-2-[(2-phenylaminoethylimino)methyl]phenolate;L2=4-[2-(2-{[1-(5-chloro-2-hydroxyphenyl)methylidene]amino}ethylamino)ethylimino]pentan-3-en-2-one),have been synthesized and characterized by physico-chemical methods and single-crystal X-ray diffraction.The V atom in the mononuclear complex 1 is in distorted square pyramidal coordination,and those in the dinuclear complex 2 are in octahedral coordination.The complexes were tested for their Helicobacter pylori urease inhibitory activity.The inhibition rate of the complexes 1 and 2 at the concentration of 100 μmol·L-1against urease are (52.1±1.8)%,and (34.2±3.3)%.The molecular docking study of the complexes with the Helicobacter pylori urease was performed.The relationship between the structures of the complexes and the urease inhibitory activities indicates that the size and shape of the complex molecules play an important role for the inhibition.CCDC:832899,1;832900,2.

Schiff base;oxovanadium(Ⅴ)complex;crystal structure;urease inhibition

O614.51+1

A

1001-4861(2012)06-1271-08

2011-07-06。收修改稿日期：2012-02-21。

國家自然科學(xué)基金(No.20901036)，遼寧省高校優(yōu)秀青年人才支持計劃(No.LJQ2011114)資助項目。

＊通訊聯(lián)系人。E-mail：youzhonglu@yahoo.com.cn